Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism
Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2017-10, Vol.120 (8), p.1393-1398 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1398 |
|---|---|
| container_issue | 8 |
| container_start_page | 1393 |
| container_title | The American journal of cardiology |
| container_volume | 120 |
| creator | Carroll, Brett J. Pemberton, Heather Bauer, Kenneth A. Chu, Louis M. Weinstein, Jeffrey L. Levarge, Barbara L. Pinto, Duane S. |
| description | Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot On-call Team (MASCOT) was created at our institution, which comprised specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery. MASCOT offers rapid consultation 24 hours a day with a web-based conference call to review patient data and discuss management of patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to analyze patient clinical characteristics and outcomes and describe the composition and operation of the team. Between August 2015 and September 2016, MASCOT evaluated 72 patients. Seventy of the 72 patients were admitted to our institution, accounting for 32% of all patients discharged with a primary diagnosis of PE. Average age was 62 ± 17 years with a female predominance (63%). Active malignancy (31%), recent surgery or trauma (21%), and recent hospitalization (24%) were common. PE clinical severity was massive in 16% and submassive in 83%. Patients were managed with anticoagulation alone in 65% (n = 46), systemic fibrinolysis in 11% (n = 8), catheter-directed therapy in 18% (n = 13), extracorporeal membrane oxygenation in 3% (n = 2), and an inferior vena cava filter was placed in 15% (n = 11). Thirteen percent (n = 9) experienced a major bleed with no intracranial hemorrhage. Survival to discharge was 89% (64% with massive PE and 93% with submassive PE). In conclusion, multidisciplinary, rapid response PE teams offer a unique coordinated approach to patient care. |
| doi_str_mv | 10.1016/j.amjcard.2017.07.033 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1929105558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914917311980</els_id><sourcerecordid>1945869884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-5c738c14a91cca7f900a2d807a8c02c1de3de33c601b110623d7d832a94646773</originalsourceid><addsrcrecordid>eNqFkUtLLDEQhYNc0fHxE5TA3biwx6pOP5KViPgCRfGxDpkkA2m6O23SLfjvzTCjCzdCQSj4TqXqHEKOEOYIWJ01c9U1WgUzzwHrOaRibIvMkNciQ4HsH5kBQJ4JLMQu2YuxSS1iWe2Q3ZxzqAsoZ0Tf9W50anS-p35JFX2Y2tEZF7UbWter8HlKn9XgDH22cfB9tPTVqo6Onj6oGN2Hpao39GVadJv2aWo7vxLSq27hWxe7A7K9VG20h5t3n7xdX71e3mb3jzd3lxf3mWaCjVmpa8Y1Fkqg1qpeCgCVm7So4hpyjcayVExXgAtEqHJmasNZrkRRFVVds31ysp47BP8-2TjKLt1h21b11k9RosgFQlmWPKH_f6GNn0KftktUUfJKcF4kqlxTOvgYg13KIbgunSYR5CoF2chNCnKVgoRUjCXd8WZ6ssWaH9W37Qk4XwM22fHhbJDJb9tra1ywepTGuz---AIyV5pW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1945869884</pqid></control><display><type>article</type><title>Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Carroll, Brett J. ; Pemberton, Heather ; Bauer, Kenneth A. ; Chu, Louis M. ; Weinstein, Jeffrey L. ; Levarge, Barbara L. ; Pinto, Duane S.</creator><creatorcontrib>Carroll, Brett J. ; Pemberton, Heather ; Bauer, Kenneth A. ; Chu, Louis M. ; Weinstein, Jeffrey L. ; Levarge, Barbara L. ; Pinto, Duane S.</creatorcontrib><description>Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot On-call Team (MASCOT) was created at our institution, which comprised specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery. MASCOT offers rapid consultation 24 hours a day with a web-based conference call to review patient data and discuss management of patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to analyze patient clinical characteristics and outcomes and describe the composition and operation of the team. Between August 2015 and September 2016, MASCOT evaluated 72 patients. Seventy of the 72 patients were admitted to our institution, accounting for 32% of all patients discharged with a primary diagnosis of PE. Average age was 62 ± 17 years with a female predominance (63%). Active malignancy (31%), recent surgery or trauma (21%), and recent hospitalization (24%) were common. PE clinical severity was massive in 16% and submassive in 83%. Patients were managed with anticoagulation alone in 65% (n = 46), systemic fibrinolysis in 11% (n = 8), catheter-directed therapy in 18% (n = 13), extracorporeal membrane oxygenation in 3% (n = 2), and an inferior vena cava filter was placed in 15% (n = 11). Thirteen percent (n = 9) experienced a major bleed with no intracranial hemorrhage. Survival to discharge was 89% (64% with massive PE and 93% with submassive PE). In conclusion, multidisciplinary, rapid response PE teams offer a unique coordinated approach to patient care.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2017.07.033</identifier><identifier>PMID: 28807405</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anticoagulants ; Anticoagulants - therapeutic use ; Bleeding ; Cardiology ; Catheters ; Consultation ; Embolism ; Embolisms ; Extracorporeal Membrane Oxygenation - methods ; Female ; Fibrinolysis ; Follow-Up Studies ; Health risk assessment ; Heart diseases ; Heart surgery ; Hematology ; Hemorrhage ; Hospitals ; Humans ; Male ; Malignancy ; Massachusetts - epidemiology ; Medical instruments ; Medical records ; Middle Aged ; Mortality ; Oxygenation ; Patient Care Team - standards ; Patients ; Pulmonary arteries ; Pulmonary Embolism - mortality ; Pulmonary Embolism - therapy ; Pulmonary embolisms ; Radiology ; Retrospective Studies ; Risk management ; Surgery ; Survival Rate - trends ; Teams ; Thrombectomy - methods ; Thromboembolism ; Thrombolytic Therapy - methods ; Thrombosis ; Trauma ; Treatment Outcome ; Vena Cava Filters</subject><ispartof>The American journal of cardiology, 2017-10, Vol.120 (8), p.1393-1398</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Sequoia S.A. Oct 15, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-5c738c14a91cca7f900a2d807a8c02c1de3de33c601b110623d7d832a94646773</citedby><cites>FETCH-LOGICAL-c393t-5c738c14a91cca7f900a2d807a8c02c1de3de33c601b110623d7d832a94646773</cites><orcidid>0000-0002-6704-5663</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1945869884?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28807405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carroll, Brett J.</creatorcontrib><creatorcontrib>Pemberton, Heather</creatorcontrib><creatorcontrib>Bauer, Kenneth A.</creatorcontrib><creatorcontrib>Chu, Louis M.</creatorcontrib><creatorcontrib>Weinstein, Jeffrey L.</creatorcontrib><creatorcontrib>Levarge, Barbara L.</creatorcontrib><creatorcontrib>Pinto, Duane S.</creatorcontrib><title>Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot On-call Team (MASCOT) was created at our institution, which comprised specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery. MASCOT offers rapid consultation 24 hours a day with a web-based conference call to review patient data and discuss management of patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to analyze patient clinical characteristics and outcomes and describe the composition and operation of the team. Between August 2015 and September 2016, MASCOT evaluated 72 patients. Seventy of the 72 patients were admitted to our institution, accounting for 32% of all patients discharged with a primary diagnosis of PE. Average age was 62 ± 17 years with a female predominance (63%). Active malignancy (31%), recent surgery or trauma (21%), and recent hospitalization (24%) were common. PE clinical severity was massive in 16% and submassive in 83%. Patients were managed with anticoagulation alone in 65% (n = 46), systemic fibrinolysis in 11% (n = 8), catheter-directed therapy in 18% (n = 13), extracorporeal membrane oxygenation in 3% (n = 2), and an inferior vena cava filter was placed in 15% (n = 11). Thirteen percent (n = 9) experienced a major bleed with no intracranial hemorrhage. Survival to discharge was 89% (64% with massive PE and 93% with submassive PE). In conclusion, multidisciplinary, rapid response PE teams offer a unique coordinated approach to patient care.</description><subject>Anticoagulants</subject><subject>Anticoagulants - therapeutic use</subject><subject>Bleeding</subject><subject>Cardiology</subject><subject>Catheters</subject><subject>Consultation</subject><subject>Embolism</subject><subject>Embolisms</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Female</subject><subject>Fibrinolysis</subject><subject>Follow-Up Studies</subject><subject>Health risk assessment</subject><subject>Heart diseases</subject><subject>Heart surgery</subject><subject>Hematology</subject><subject>Hemorrhage</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Male</subject><subject>Malignancy</subject><subject>Massachusetts - epidemiology</subject><subject>Medical instruments</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Oxygenation</subject><subject>Patient Care Team - standards</subject><subject>Patients</subject><subject>Pulmonary arteries</subject><subject>Pulmonary Embolism - mortality</subject><subject>Pulmonary Embolism - therapy</subject><subject>Pulmonary embolisms</subject><subject>Radiology</subject><subject>Retrospective Studies</subject><subject>Risk management</subject><subject>Surgery</subject><subject>Survival Rate - trends</subject><subject>Teams</subject><subject>Thrombectomy - methods</subject><subject>Thromboembolism</subject><subject>Thrombolytic Therapy - methods</subject><subject>Thrombosis</subject><subject>Trauma</subject><subject>Treatment Outcome</subject><subject>Vena Cava Filters</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUtLLDEQhYNc0fHxE5TA3biwx6pOP5KViPgCRfGxDpkkA2m6O23SLfjvzTCjCzdCQSj4TqXqHEKOEOYIWJ01c9U1WgUzzwHrOaRibIvMkNciQ4HsH5kBQJ4JLMQu2YuxSS1iWe2Q3ZxzqAsoZ0Tf9W50anS-p35JFX2Y2tEZF7UbWter8HlKn9XgDH22cfB9tPTVqo6Onj6oGN2Hpao39GVadJv2aWo7vxLSq27hWxe7A7K9VG20h5t3n7xdX71e3mb3jzd3lxf3mWaCjVmpa8Y1Fkqg1qpeCgCVm7So4hpyjcayVExXgAtEqHJmasNZrkRRFVVds31ysp47BP8-2TjKLt1h21b11k9RosgFQlmWPKH_f6GNn0KftktUUfJKcF4kqlxTOvgYg13KIbgunSYR5CoF2chNCnKVgoRUjCXd8WZ6ssWaH9W37Qk4XwM22fHhbJDJb9tra1ywepTGuz---AIyV5pW</recordid><startdate>20171015</startdate><enddate>20171015</enddate><creator>Carroll, Brett J.</creator><creator>Pemberton, Heather</creator><creator>Bauer, Kenneth A.</creator><creator>Chu, Louis M.</creator><creator>Weinstein, Jeffrey L.</creator><creator>Levarge, Barbara L.</creator><creator>Pinto, Duane S.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6704-5663</orcidid></search><sort><creationdate>20171015</creationdate><title>Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism</title><author>Carroll, Brett J. ; Pemberton, Heather ; Bauer, Kenneth A. ; Chu, Louis M. ; Weinstein, Jeffrey L. ; Levarge, Barbara L. ; Pinto, Duane S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-5c738c14a91cca7f900a2d807a8c02c1de3de33c601b110623d7d832a94646773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants - therapeutic use</topic><topic>Bleeding</topic><topic>Cardiology</topic><topic>Catheters</topic><topic>Consultation</topic><topic>Embolism</topic><topic>Embolisms</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Female</topic><topic>Fibrinolysis</topic><topic>Follow-Up Studies</topic><topic>Health risk assessment</topic><topic>Heart diseases</topic><topic>Heart surgery</topic><topic>Hematology</topic><topic>Hemorrhage</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Male</topic><topic>Malignancy</topic><topic>Massachusetts - epidemiology</topic><topic>Medical instruments</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Oxygenation</topic><topic>Patient Care Team - standards</topic><topic>Patients</topic><topic>Pulmonary arteries</topic><topic>Pulmonary Embolism - mortality</topic><topic>Pulmonary Embolism - therapy</topic><topic>Pulmonary embolisms</topic><topic>Radiology</topic><topic>Retrospective Studies</topic><topic>Risk management</topic><topic>Surgery</topic><topic>Survival Rate - trends</topic><topic>Teams</topic><topic>Thrombectomy - methods</topic><topic>Thromboembolism</topic><topic>Thrombolytic Therapy - methods</topic><topic>Thrombosis</topic><topic>Trauma</topic><topic>Treatment Outcome</topic><topic>Vena Cava Filters</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carroll, Brett J.</creatorcontrib><creatorcontrib>Pemberton, Heather</creatorcontrib><creatorcontrib>Bauer, Kenneth A.</creatorcontrib><creatorcontrib>Chu, Louis M.</creatorcontrib><creatorcontrib>Weinstein, Jeffrey L.</creatorcontrib><creatorcontrib>Levarge, Barbara L.</creatorcontrib><creatorcontrib>Pinto, Duane S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carroll, Brett J.</au><au>Pemberton, Heather</au><au>Bauer, Kenneth A.</au><au>Chu, Louis M.</au><au>Weinstein, Jeffrey L.</au><au>Levarge, Barbara L.</au><au>Pinto, Duane S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2017-10-15</date><risdate>2017</risdate><volume>120</volume><issue>8</issue><spage>1393</spage><epage>1398</epage><pages>1393-1398</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot On-call Team (MASCOT) was created at our institution, which comprised specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery. MASCOT offers rapid consultation 24 hours a day with a web-based conference call to review patient data and discuss management of patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to analyze patient clinical characteristics and outcomes and describe the composition and operation of the team. Between August 2015 and September 2016, MASCOT evaluated 72 patients. Seventy of the 72 patients were admitted to our institution, accounting for 32% of all patients discharged with a primary diagnosis of PE. Average age was 62 ± 17 years with a female predominance (63%). Active malignancy (31%), recent surgery or trauma (21%), and recent hospitalization (24%) were common. PE clinical severity was massive in 16% and submassive in 83%. Patients were managed with anticoagulation alone in 65% (n = 46), systemic fibrinolysis in 11% (n = 8), catheter-directed therapy in 18% (n = 13), extracorporeal membrane oxygenation in 3% (n = 2), and an inferior vena cava filter was placed in 15% (n = 11). Thirteen percent (n = 9) experienced a major bleed with no intracranial hemorrhage. Survival to discharge was 89% (64% with massive PE and 93% with submassive PE). In conclusion, multidisciplinary, rapid response PE teams offer a unique coordinated approach to patient care.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28807405</pmid><doi>10.1016/j.amjcard.2017.07.033</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6704-5663</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2017-10, Vol.120 (8), p.1393-1398 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1929105558 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Anticoagulants Anticoagulants - therapeutic use Bleeding Cardiology Catheters Consultation Embolism Embolisms Extracorporeal Membrane Oxygenation - methods Female Fibrinolysis Follow-Up Studies Health risk assessment Heart diseases Heart surgery Hematology Hemorrhage Hospitals Humans Male Malignancy Massachusetts - epidemiology Medical instruments Medical records Middle Aged Mortality Oxygenation Patient Care Team - standards Patients Pulmonary arteries Pulmonary Embolism - mortality Pulmonary Embolism - therapy Pulmonary embolisms Radiology Retrospective Studies Risk management Surgery Survival Rate - trends Teams Thrombectomy - methods Thromboembolism Thrombolytic Therapy - methods Thrombosis Trauma Treatment Outcome Vena Cava Filters |
| title | Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A46%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initiation%20of%20a%20Multidisciplinary,%20Rapid%20Response%20Team%20to%20Massive%20and%20Submassive%20Pulmonary%20Embolism&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Carroll,%20Brett%20J.&rft.date=2017-10-15&rft.volume=120&rft.issue=8&rft.spage=1393&rft.epage=1398&rft.pages=1393-1398&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2017.07.033&rft_dat=%3Cproquest_cross%3E1945869884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1945869884&rft_id=info:pmid/28807405&rft_els_id=S0002914917311980&rfr_iscdi=true |